[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Zentrum fur Humangenetik Tuebingen\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":17,"phases":4,"briefSummary":18,"conditions":19,"keywords":4,"overallStatus":21,"whyStopped":4,"lastUpdateSubmitDate":22,"lastUpdatePostDateStruct":23,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":26,"locationsCount":5},"100466636","glioblastoma-and-individualized-therapies-100466636",false,"NCT05356312","Glioblastoma and Individualized Therapies","Retrospective Analysis of Glioblastoma Patients With Immune Therapies","Inclusion Criteria:\n\n* malignant glioma, IDH WT\n\nExclusion Criteria:\n\n* na","ALL","EXPANDED_ACCESS","The treatment of patients with World Health Organization (WHO) grade 4 malignant glioma has not seen any significant breakthrough the past years. Following surgery and radio \u002F chemotherapy patients still experience a very high recurrence risk and the prognosis is dismal. The investigators observed patients with grade IV malignant glioma receiving individualized treatment based on their molecular profile including fully personalized vaccines.",[20],"Glioma, Malignant","AVAILABLE","2024-02-29",{"date":24,"type":25},"2024-03-01","ACTUAL",{"name":27,"class":28},"Zentrum fur Humangenetik Tuebingen","OTHER",""]